Literature DB >> 11792960

Some tumors of the bladder are polyclonal in origin.

Thomas Paiss1, Gudrun Wöhr, Richard E Hautmann, Torsten Mattfeldt, Markus Müller, Juergen Haeussler, Walther Vogel.   

Abstract

PURPOSE: Clonality assays can be used to address different questions of neoplasm development. The study of the X chromosome inactivation pattern in female patients provides a useful and most commonly used indirect approach to demonstrate the monoclonal status of a cell population. We used this approach to examine whether recurrent tumors of the bladder supposed to be of monoclonal origin derive from different, independently transformed cells or whether they arise from 1 primary tumor.
MATERIALS AND METHODS: We analyzed 45 archival or fresh frozen bladder tumors from 27 female patients. We assessed the X inactivation status of each tumor by a polymerase chain reaction based method after HpaII digestion.
RESULTS: Surprisingly 16 of the 45 tumors revealed a polyclonal pattern. The amount of undigested DNA far exceeded what was explained by contamination with normal cells, as determined on histological sections indicating that these tumors were in fact polyclonal. This polyclonal status was further confirmed by a comprehensive series of controls.
CONCLUSIONS: Some bladder tumors are polyclonal in origin. Our findings are at variance with earlier observations and possibilities for explanation are proposed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11792960     DOI: 10.1097/00005392-200202000-00072

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Wnt/β-Catenin Signalling and Its Cofactor BCL9L Have an Oncogenic Effect in Bladder Cancer Cells.

Authors:  Roland Kotolloshi; Mieczyslaw Gajda; Marc-Oliver Grimm; Daniel Steinbach
Journal:  Int J Mol Sci       Date:  2022-05-10       Impact factor: 6.208

2.  CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer.

Authors:  Akira Ooki; Christopher J VandenBussche; Max Kates; Noah M Hahn; Andres Matoso; David J McConkey; Trinity J Bivalacqua; Mohammad Obaidul Hoque
Journal:  Br J Cancer       Date:  2018-10-17       Impact factor: 7.640

3.  Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation.

Authors:  H Kawanishi; T Takahashi; M Ito; Y Matsui; J Watanabe; N Ito; T Kamoto; T Kadowaki; G Tsujimoto; I Imoto; J Inazawa; H Nishiyama; O Ogawa
Journal:  Br J Cancer       Date:  2007-06-19       Impact factor: 7.640

4.  Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma.

Authors:  Kunyoo Shin; Agnes Lim; Justin I Odegaard; Jared D Honeycutt; Sally Kawano; Michael H Hsieh; Philip A Beachy
Journal:  Nat Cell Biol       Date:  2014-04-20       Impact factor: 28.824

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.